1. Most Discussed
  2. Gainers & Losers
PRR 3.8¢

wakey wakey mr market

  1. nuts

    701 posts.
    Positive Phase 2 results are typically the trigger for big pharma to step in.
    This attention will drive the price up, whether a deal is made or PRR decide to do it on their own and raise capital.
    With less doubt around efficacy, we can start projecting the potential pricing on the final product with a bit more certainty.
    With a better idea of future earnings, we get closer to the traditional rules of valuing companies. Using the average biotech P/E ratio, for example.
    Then it's just working out how quickly we can attain peak sales of a given market share.

    My crystal ball says the price would spike on the news and climb for a few sessions up about 200% before profit taking drops it back down 30 or 40%. Then it will trade around those levels for a weeks as SM accumulates, raising it another 10-15%.
    They'll sell out and perhaps start shorting in order to trigger stop losses and scare the retail investors and accumulate further.
    Prima will announce they've secured a breakthrough designation which expedites the P3 trial. FDA has a look at the interim data and decides it's in the best interests of the patients that the control arm receive CVac and conditionally approve it for commercialisation and adjust the P3 to continue as a confirmation trial.
    Market Cap increases 2000%, then another 5000% as the additional trials potentially prove CVac works in all MUC-1 over-expressing cancers.

    Either that or it crashes on Oct 2.

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.